{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:12:12Z","timestamp":1792620732028,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011260","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000}}],"reference-count":129,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011260.pub2","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T18:32:57Z","timestamp":1575484377000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Agust\u00edn","family":"Ciapponi","sequence":"first","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Bardach","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucila","family":"Rey Ares","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demi\u00e1n","family":"Glujovsky","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"},{"name":"CEGYR (Centro de Estudios en Gen\u00e9tica y Reproducci\u00f3n); Reproductive Medicine; Viamonte 1432, Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Cafferata","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Cesaroni","sequence":"additional","affiliation":[{"name":"Institute for Clinical Effectiveness and Health Policy (IECS-CONICET); Argentine Cochrane Centre; Buenos Aires Argentina C1414CPV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikant","family":"Bhatti","sequence":"additional","affiliation":[{"name":"World Health Organization; 1085, Sector-B,Pocket-1, Vasant Kunj New Delhi India 110070"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"14","key":"10.1002\/14651858.CD011260.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"issue":"48","key":"10.1002\/14651858.CD011260.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"Asturias","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1542\/peds.107.4.671","article-title":"Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations","volume":"107","author":"Davis","year":"2001","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0007|cit5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00006454-199112000-00030","article-title":"Results of a clinical study of polio vaccine: the Buffalo experience","volume":"10","author":"Faden","year":"1991","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0005|cit6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/infdis\/168.2.452","article-title":"Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines","volume":"168","author":"Faden","year":"1993","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0006|cit7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD011260.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/00006454-199707000-00010","article-title":"Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b\/hepatitis B vaccine","volume":"16","author":"Halsey","year":"1997","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18821\/0507-4088-2016-61-1-9-15","article-title":"Vaccine-associated paralytic poliomyelitis in Russian Federation during the period of changes in vaccination schedule (2006-2013 yy.)","volume":"61","author":"Ivanova","year":"2016","journal-title":"Voprosy Virusologii"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijid.2018.08.017","article-title":"Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998-2014","volume":"76","author":"Ivanova","year":"2018","journal-title":"International Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF02737758","article-title":"Seroconversion following killed polio vaccine in neonates","volume":"64","author":"Jain","year":"1997","journal-title":"Indian Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1574-695X.2009.00621.x","article-title":"Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary","volume":"58","author":"Kapusinszky","year":"2010","journal-title":"FEMS Immunology and Medical Microbiology"},{"issue":"3","key":"10.1002\/14651858.CD011260.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jpids\/piv017","article-title":"Immunogenicity of two different sequential schedules of inactivated polio vaccine followed by oral polio vaccine versus oral polio vaccine alone in healthy infants in China","volume":"5","author":"Li","year":"2016","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"F24","DOI":"10.1136\/fn.83.1.f24","article-title":"Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth","volume":"83","author":"Linder","year":"2000","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group","volume":"175 Suppl 1","author":"Modlin","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011260.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/cid\/ciy603","article-title":"Intestinal immunity to poliovirus following sequential trivalent inactivated polio vaccine\/bivalent oral polio vaccine and trivalent inactivated polio vaccine-only immunization schedules: analysis of an open-label, randomized, controlled trial in Chilean infants","volume":"67","author":"Brickley","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD011260.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O'Ryan","year":"2015","journal-title":"Lancet. Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1080\/21645515.2017.1288769","article-title":"Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: a randomized controlled non-inferiority clinical trial","volume":"13","author":"Qiu","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/00006454-199412000-00009","article-title":"Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines","volume":"13","author":"Ramsay","year":"1994","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"10","key":"10.1002\/14651858.CD011260.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1086\/503366","article-title":"Analysis of reversions in the 5\u2032-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines","volume":"193","author":"Laassri","year":"2006","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/00006454-200005000-00006","article-title":"Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis\/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination","volume":"19","author":"Rennels","year":"2000","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3109\/00365549409008643","article-title":"Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants","volume":"26","author":"Simasathien","year":"1994","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1093\/infdis\/175.Supplement_1.S235","article-title":"Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman","volume":"175 Suppl 1","author":"Sutter","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"S471","DOI":"10.1093\/clinids\/6.Supplement_2.S471","article-title":"Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark","volume":"6 Suppl 2","author":"Magnus","year":"1984","journal-title":"Reviews of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2165\/00063030-200115060-00007","article-title":"Antibody responses of healthy infants to concurrent administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine with diphtheria-tetanus-pertussis, polio and measles-mumps-rubella vaccines","volume":"15","author":"West","year":"2001","journal-title":"Biodrugs"},{"issue":"10","key":"10.1002\/14651858.CD011260.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/00006454-200110000-00011","article-title":"Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants","volume":"20","author":"Yeh","year":"2001","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.vaccine.2016.02.010","article-title":"Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China","volume":"34","author":"Li","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpedi.1969.02100030163008","article-title":"Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine","volume":"117","author":"McCollough","year":"1969","journal-title":"American Journal of Diseases of Children"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0030|cit30","first-page":"85","article-title":"Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine","volume":"-","author":"Mo\u01d0seieva","year":"2002","journal-title":"Likars'ka sprava"},{"issue":"20","key":"10.1002\/14651858.CD011260.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/S0264-410X(98)00071-1","article-title":"Immune response to an intercalated enhanced inactivated polio vaccine\/oral polio vaccine programme in Israel: impact on the control of poliomyelitis","volume":"16","author":"Swartz","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1542\/peds.107.5.e83","article-title":"Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine","volume":"107","author":"Wattigney","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3760\/cma.j.issn.0253-9624.2018.01.009","article-title":"[Comparing the immunogenicity and safety of sequential inoculation of sIPV followed by bOPV (I + III) in different dosage forms]","volume":"52","author":"Ye","year":"2018","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0034|cit34","unstructured":"NCT02412514 Intestinal and humoral immunity of sequential polio vaccination schedules. clinicaltrials.gov\/ct2\/show\/NCT02412514"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0035|cit35","unstructured":"NCT03430349 Phase 1 novel live attenuated serotype 2 oral polio vaccine study in IPV primed adults (nOPV2M4a) clinicaltrials.gov\/ct2\/show\/NCT03430349"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0036|cit36","unstructured":"NCT03614702 Clinic trial to evaluate the safety and immunogenicity by different sequential schedules of bOPV and IPV clinicaltrials.gov\/show\/nct03614702"},{"issue":"3","key":"10.1002\/14651858.CD011260.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.inf.0000256735.05098.01","article-title":"Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau","volume":"26","author":"Aaby","year":"2007","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"22","key":"10.1002\/14651858.CD011260.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"issue":"10040","key":"10.1002\/14651858.CD011260.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011260.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/cid\/ciy633","article-title":"Immunogenicity of new primary immunization schedules with inactivated poliovirus vaccine and bivalent oral polio vaccine for the polio endgame: a review","volume":"67","author":"Bandyopadhyay","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011260.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF03320615","article-title":"Economic evaluation of the sequential schedule of polio vaccination in Italy","volume":"5","author":"Biffi","year":"2003","journal-title":"PharmacoEconomics - Italian Research Articles"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011260.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/cid\/ciy603","article-title":"Intestinal immunity to poliovirus following sequential trivalent inactivated polio vaccine\/bivalent oral polio vaccine and trivalent inactivated polio vaccine-only immunization schedules: analysis of an open-label, randomized, controlled trial in Chilean infants","volume":"67","author":"Brickley","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"issue":"RR-3","key":"10.1002\/14651858.CD011260.pub2-BIB0044|cit44","first-page":"1","article-title":"Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"Morbidity and Mortality Weekly Report. Recommendations and Reports"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0045|cit45","unstructured":"Centers for Disease Control and Prevention Updates on CDC\u2019s polio eradication efforts www.cdc.gov\/polio\/updates\/2015\/2015-1211.htm"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0046|cit46","unstructured":"Ciapponi A Glujovsky D Bardach A Garc\u00eda Mart\u00ed S Comande D EROS: a new software for early stage of systematic reviews HTA for Health Systems Sustainability 8th Annual Meeting; 2011 Jun 27-9; Rio de Janeiro (BR) 2011 66"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0047|cit47","unstructured":"Ciapponi A Gibbons L Global incidence of circulating vaccine-derived poliovirus (cVDPV) during the period 2000-2016: meta-analysis XVI Reuni\u00f3n Anual de la Red Cochrane Iberoamericana: S\u00edntesis y transferencia del conocimiento; 2017 Jun 5-7; Medell\u00edn (CO) 2017"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0048|cit48","first-page":"143","article-title":"The work of the WHO Consultative Group on poliomyelitis vaccines","volume":"66","author":"Cockburn","year":"1988","journal-title":"Bulletin of the World Health Organization"},{"issue":"15","key":"10.1002\/14651858.CD011260.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"Cuba IPV Study Collaborative Group","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/321905","article-title":"Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication","volume":"33","author":"C\u00e1ceres","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ije\/29.4.757","article-title":"Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil","volume":"29","author":"Oliveira","year":"2000","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"DerSimonian R Laird N Meta-analysis in clinical trials Controlled Clinical Trials 1986 177 88","DOI":"10.1016\/0197-2456(86)90046-2"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1155\/2014\/378320","article-title":"An unusual case of vaccine-associated paralytic poliomyelitis","volume":"25","author":"Desai","year":"2014","journal-title":"Canadian Journal of Infectious Diseases & Medical Microbiology"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0054|cit54","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian Journal of Medical Research"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1093\/infdis\/jit588","article-title":"Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program","volume":"210 Suppl 1","author":"Domingues","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3760\/cma.j.issn.0253-9624.2016.12.003","article-title":"The role of Sabin inactivated poliovirus vaccine in the final phase of global polio eradication","volume":"50","author":"Dong","year":"2016","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1539-6924.2006.00842.x","article-title":"The costs of future polio risk management policies","volume":"26","author":"Duintjer Tebbens","year":"2006","journal-title":"Risk Analysis"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12879-015-1112-8","article-title":"An economic analysis of poliovirus risk management policy options for 2013-2052","volume":"15","author":"Duintjer Tebbens","year":"2015","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0059|cit59","unstructured":"Effective Practice Organisation of Care Cochrane Effective Practice and Organisation of Care Review Group: data collection checklist bit.ly\/1zXPg9y"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0060|cit60","unstructured":"Effective Practice Organisation of Care Draft EPOC methods paper: including Interrupted Time Series (ITS) designs in a EPOC review bit.ly\/1Eq6Zbf"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0061|cit61","unstructured":"Effective Practice Organisation of Care Presentation of data from EPOC studies (RCTs and CBAs) bit.ly\/1y5dRDI"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0062|cit62","unstructured":"Cochrane Effective Practice Organisation of Care (EPOC) Suggested risk of bias criteria for EPOC reviews epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/public\/uploads\/Resources-for-authors2017\/suggested_risk_of_bias_criteria_for_epoc_reviews.pdf"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/infdis\/168.1.25","article-title":"Poliovirus vaccination: a trilogy","volume":"168","author":"Faden","year":"1993","journal-title":"Journal\u00a0of Infectious Diseases"},{"issue":"10023","key":"10.1002\/14651858.CD011260.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(16)00661-9","article-title":"Changing oral vaccine to inactivated polio vaccine might increase mortality","volume":"387","author":"Fish","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","article-title":"Polio endgame: the global switch from tOPV to bOPV","volume":"15","author":"Garon","year":"2016","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.5546\/aap.2016.eng.557","article-title":"A new challenge for the world: the eradication of polio","volume":"114","author":"Gentile","year":"2016","journal-title":"Archivos Argentinos De Pediatria"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0067|cit67","unstructured":"Glujovsky D Bardach A Garc\u00eda Mart\u00ed S Comande D Ciapponi A New software for early stage of systematic reviews XVIII Cochrane Colloquium. The Joint Colloquium of the Cochrane and Campbell Collaborations; 2010 Oct 18-22 2010"},{"issue":"7","key":"10.1002\/14651858.CD011260.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"A564","DOI":"10.1016\/j.jval.2011.08.1689","article-title":"EROS: a new software for early stage of systematic reviews","volume":"14","author":"Glujovsky","year":"2011","journal-title":"Value in Health"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1155\/1994\/153783","article-title":"Enhanced inactivated poliovirus vaccine","volume":"5","author":"Gold","year":"1994","journal-title":"Canadian Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0070|cit70","unstructured":"Global Polio Eradication Initiative Global wild poliovirus 2012 - 2018 polioeradication.org\/wp-content\/uploads\/2018\/01\/global-wild-poliovirus-2012-2018-20180110.pdf"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0071|cit71","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"5802","key":"10.1002\/14651858.CD011260.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1086\/605330","article-title":"Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India","volume":"200","author":"Grassly","year":"2009","journal-title":"Journal\u00a0of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"S439","DOI":"10.1093\/infdis\/jit601","article-title":"Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis","volume":"210 Suppl 1","author":"Grassly","year":"2014","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0075|cit75","doi-asserted-by":"crossref","unstructured":"Guyatt G Oxman AD Akl EA Kunz R Vist G Brozek J GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables Journal of Clinical Epidemiology 2011 383 94 10.1016\/j.jclinepi.2010.04.026","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"issue":"49","key":"10.1002\/14651858.CD011260.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1016\/j.vaccine.2012.09.059","article-title":"Adjuvants and inactivated polio vaccine: a systematic review","volume":"30","author":"Hawken","year":"2012","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0077|cit77","doi-asserted-by":"crossref","unstructured":"Higgins JP Thompson SG Deeks JJ Altman DG Measuring inconsistency in meta-analyses BMJ 2003 557 60 10.1136\/bmj.327.7414.557","DOI":"10.1136\/bmj.327.7414.557"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0078|cit78","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0079|cit79","unstructured":"Higgins JP Altman DG Sterne JAC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0080|cit80","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD011260.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLOS Pathogens"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"30","key":"10.1002\/14651858.CD011260.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"763","DOI":"10.15585\/mmwr.mm6530a3","article-title":"Update on vaccine-derived polioviruses - worldwide, January 2015 - May 2016","volume":"65","author":"Jorba","year":"2016","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0084|cit84","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD011260.pub2-BIB0085|cit85","first-page":"210","article-title":"Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine","volume":"80","author":"Kohler","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1542\/peds.60.1.80","article-title":"Antibody persistence after primary immunization with trivalent oral poliovirus vaccine","volume":"60","author":"Krugman","year":"1977","journal-title":"Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1086\/498172","article-title":"Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains","volume":"192","author":"Laassri","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"10.1002\/14651858.CD011260.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/infdis\/jit602","article-title":"Vaccine-associated paralytic poliomyelitis in the postelimination era in Latin America and the Caribbean, 1992-2011","volume":"209","author":"Landaverde","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011260.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/infdis\/jiw550","article-title":"A supply and demand management perspective on the accelerated global introductions of inactivated poliovirus vaccine in a constrained supply market","volume":"216","author":"Lewis","year":"2017","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0090|cit90","doi-asserted-by":"crossref","unstructured":"Liberati A Altman DG Tetzlaff J Mulrow C G\u00f8tzsche PC Ioannidis JPA The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLOS Medicine 2009 e1000100 10.1371\/journal.pmed.1000100","DOI":"10.1371\/journal.pmed.1000100"},{"issue":"9","key":"10.1002\/14651858.CD011260.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.vaccine.2017.01.034","article-title":"Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014","volume":"35","author":"Liu","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD011260.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0950268816002569","article-title":"Wild and vaccine-derived poliovirus circulation, and implications for polio eradication","volume":"145","author":"Lopalco","year":"2017","journal-title":"Epidemiology and Infection"},{"issue":"10","key":"10.1002\/14651858.CD011260.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cid\/civ617","article-title":"The effect of oral polio vaccine at birth on infant mortality: a randomized trial","volume":"61","author":"Lund","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011260.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.puhe.2004.08.020","article-title":"Polio immunization policy in Mexico: economic assessment of current practice and future alternatives","volume":"119","author":"Mascare\u00f1as","year":"2005","journal-title":"Public Health"},{"issue":"3","key":"10.1002\/14651858.CD011260.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","article-title":"Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines","volume":"128","author":"McBean","year":"1988","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0096|cit96","first-page":"233","article-title":"The statistical analysis of the simple interrupted time-series quasi-experiment","volume-title":"Quasi-Experimentation: Design & Analysis Issues for Field Settings","author":"McCain","year":"1979"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1996.03540120045032","article-title":"Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule","volume":"276","author":"Miller","year":"1996","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD011260.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0099|cit99","unstructured":"Modlin J Chumakov K Sabin strain inactivated polio vaccine for the polio endgame Journal of Infectious Diseases 10.1093\/infdis\/jiz077"},{"issue":"7","key":"10.1002\/14651858.CD011260.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0101|cit101","unstructured":"Pan American Health Organization Switch from tOPV to bOPV www.paho.org\/hq\/index.php?option=com_content&view=article&id=11015:topv-bopv-supporting-technical-documents&Itemid=1707&lang=en"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"10147","key":"10.1002\/14651858.CD011260.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(18)30483-5","article-title":"On reducing the risk of vaccine-associated paralytic poliomyelitis in the global transition from oral to inactivated poliovirus vaccine","volume":"392","author":"Peng","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210 Suppl 1","author":"Platt","year":"2014","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011260.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0106|cit106","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"8","key":"10.1002\/14651858.CD011260.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0034-8910.2015049005492","article-title":"Polio inactivated vaccine costs into routine childhood immunization in Brazil","volume":"49","author":"Sartori","year":"2015","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0108|cit108","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P on behalf of the Cochrane Applicability and Recommendations Methods Group Chapter 12: Interpreting results and drawing conclusion. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0109|cit109","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0110|cit110","unstructured":"Sterne JA Egger M Moher D on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD011260.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1056\/NEJM199502233320804","article-title":"Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis","volume":"332","author":"Strebel","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011260.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0031-3955(05)70208-X","article-title":"Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States","volume":"47","author":"Sutter","year":"2000","journal-title":"Pediatric Clinics of North America"},{"issue":"9753","key":"10.1002\/14651858.CD011260.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD011260.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1080\/21645515.2018.1489188","article-title":"Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: a systematic review and meta-analysis","volume":"14","author":"Tang","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"13","key":"10.1002\/14651858.CD011260.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.vaccine.2015.02.013","article-title":"Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses","volume":"33","author":"Thompson","year":"2015","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0116|cit116","doi-asserted-by":"crossref","unstructured":"Ukoumunne OC Gulliford MC Chinn S Sterne JA Burney PG Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review Health Technology Assessment 1999 iii 92","DOI":"10.3310\/hta3050"},{"issue":"1","key":"10.1002\/14651858.CD011260.pub2-BIB0117|cit117","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 - conclusions and recommendations","volume":"88","author":"WHO","year":"2013","journal-title":"Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0118|cit118","unstructured":"World Health Organization Global Polio Eradication Initiative. Polio eradication & endgame strategic plan 2013-2018 polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0119|cit119","unstructured":"World Health Organization Poliomyelitis. Key facts www.who.int\/en\/news-room\/fact-sheets\/detail\/poliomyelitis"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0120|cit120","unstructured":"World Health Organization Circulating vaccine-derived poliovirus cases, 2000-2015 https:\/\/drive.google.com\/file\/d\/1sJqwL3jaZZcBjMWU3TXcMBBB7MKIKQ7H\/view?usp=sharing"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0121|cit121","unstructured":"World Health Organization Global wild poliovirus 2013-2018 polioeradication.org\/wp-content\/uploads\/2018\/03\/global-wild-poliovirus-2013-2018-20180320.pdf"},{"issue":"12","key":"10.1002\/14651858.CD011260.pub2-BIB0122|cit122","first-page":"145","article-title":"Polio vaccines: WHO position paper - March, 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0123|cit123","unstructured":"World Health Organization Polio case count extranet.who.int\/polis\/public\/CaseCount.aspx"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0124|cit124","unstructured":"World Health Organization Global Polio Eradication Initiative. Global circulating vaccine-derived poliovirus cases, 2000-17 polioeradication.org\/polio-today\/polio-now\/this-week\/circulating-vaccine-derived-poliovirus\/"},{"key":"10.1002\/14651858.CD011260.pub2-BIB0125|cit125","unstructured":"World Health Organization WHO vaccine-preventable diseases: monitoring system. 2019 global summary apps.who.int\/immunization_monitoring\/globalsummary\/schedules"},{"issue":"9","key":"10.1002\/14651858.CD011260.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.vaccine.2018.01.019","article-title":"Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015","volume":"36","author":"Wu","year":"2018","journal-title":"Vaccine"},{"issue":"10059","key":"10.1002\/14651858.CD011260.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(16)32177-8","article-title":"New poliovirus vaccine schedules","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"issue":"49","key":"10.1002\/14651858.CD011260.pub2-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.15585\/mmwr.mm6649a4","article-title":"Introduction of inactivated poliovirus vaccine and impact on vaccine-associated paralytic poliomyelitis - Beijing, China, 2014-2016","volume":"66","author":"Zhao","year":"2017","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"8","key":"10.1002\/14651858.CD011260.pub2-BIB0129|cit129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011260","article-title":"Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis","author":"Ciapponi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011260.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T04:18:41Z","timestamp":1679285921000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011260.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Developmental, Psychosocial and Learning Problems Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":129,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011260.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]}}}